Kartellverstoß = Todesstoß?

Wenn die dunkle Vergangenheit das Unternehmen einholt – ein Appell zum Umdenken statt Zudecken

Von Bettina Knötzl, Katrin Hanschitz und Thomas Voppichler Beitrag als PDF (Download) Aktuelle Entwicklungen – erhöhte Klagebereitschaft Der auf EU-Ebene spürbare Kampf für Fairness im Wettbewerb schlägt sich in Zahlen nieder, die eine klare Botschaft senden: Unfairer Wettbewerb kann massive Konsequenzen haben. Zuweilen führt der Verstoß geradewegs in die Insolvenz. Wie dem letzten Tätigkeitsbericht der…

All KNOETZL Arbitration Partners and Counsel among Who’s Who Legal’s Leaders and Future Leaders in Arbitration 2019

Florian Haugeneder named a Leader in International Arbitration; Partners Patrizia Netal and Emmanuel Kaufman as well as Counsel Natascha Tunkel named Future Leaders in Arbitration 2019

Who’s Who Legal names Partner Florian Haugeneder a Leader in International Arbitration and Partners Patrizia Netal and Emmanuel Kaufman as well as Counsel Natascha Tunkel Future Leaders in Arbitration 2019. Who’s Who Legal, a highly regarded, global reference source for companies seeking to research the qualifications and expertise of lawyers, just released their nominations for…

Are Pharmaceutical Manufacturers Permitted to Publicly Respond to Negative Media?

Advertising Prohibitions for Prescription-Only Drugs – Are pharmaceutical manufacturers permitted to publicly respond to negative media?

Germany / EU All advertising of prescription-only drugs to general public prohibited. In Germany, as in the rest of the EU, advertising for medicinal products is strictly regulated. Prescription-only medicinal products may be promoted only to healthcare professionals qualified to prescribe or supply them (Sec 10 Advertising of Medicines Act, HWG ). General advertising of…

“Failure to Warn” in Pharmaceutical Product Liability Cases

The Austrian Supreme Court clarified the role of the prescribing physicians in pharmaceutical liability cases.

Recent case law from the Austrian Supreme Court has helped clarify the role of the prescribing physician in pharmaceutical product liability cases. In the absence of clear guidance from the European Court of Justice , there has been some uncertainty in Austria – and in many EU Member States – on whether, in pharmaceutical product…

Roundtable Belgrade: What are the Advantages of Regional Arbitral Institutions?

Belgrade Roundtable Arbitration
Regional vs international arbitral institutions – which institution is right for which case? Photo Credit: Belgradevismootteam

On November 7th, the University of Belgrade Faculty of Law hosted a roundtable discussion to advance the participants’ understanding about the advantages of regional arbitral institutions – such as VIAC in Austria or BAC in Serbia – over larger, international institutions. More than 70 lawyers, general counsel and members of the Belgrade law faculty listened to opening…

    Note: You can revoke your consent at any time for the future by e-mail to